You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept study

Article metrics

Article menu
Download PDFPDF
Letter
Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept study

 

Online download statistics by month:

Online download statistics by month: December 2016 to March 2024

AbstractFullPdf
Dec 20163006557
Jan 20171211611
Feb 201765148
Mar 201748209
Apr 201745208
May 20173472
Jun 20173764
Jul 20173031
Aug 20173911
Sep 20175142
Oct 20176045
Nov 20172910
Dec 20175742
Jan 20184625027
Feb 20182133022
Mar 20181151810
Apr 201852115
May 201813855
Jun 20186311
Jul 20184232
Aug 20184043
Sep 20187952
Oct 20182122
Nov 20183321
Dec 20183410
Jan 20191862
Feb 20192771
Mar 20192732
Apr 20193141
May 20192342
Jun 20192462
Jul 20195210
Aug 20192732
Sep 20194554
Oct 20192444
Nov 20193084
Dec 20192176
Jan 20202100
Feb 20201510
Mar 20202943
Apr 20202242
May 20202853
Jun 20202600
Jul 20201911
Aug 2020811
Sep 20203300
Oct 20203647
Nov 20202512
Dec 20201600
Jan 20211841
Feb 20213600
Mar 20211000
Apr 2021400
May 2021853
Jun 2021641
Jul 2021622
Aug 2021611
Sep 2021420
Oct 2021900
Nov 2021811
Dec 20211200
Jan 20222721
Feb 20222421
Mar 20222521
Apr 20222621
May 20225340
Jun 20224840
Jul 20222901
Aug 20225322
Sep 20223831
Oct 20224753
Nov 20221400
Dec 20222020
Jan 2023710
Feb 20236100
Mar 2023710
Apr 2023600
May 20231800
Jun 2023620
Jul 2023800
Aug 2023810
Sep 2023620
Oct 20231400
Nov 20231932
Dec 20234220
Jan 20241411
Feb 20241300
Mar 2024733
Total3602439265